Instem Reports Increased Market Demand for KnowledgeScan Target Safety Assessment Service
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Dec 17, 2018--Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce that demand for its KnowledgeScan™ target safety assessment (TSA) service for biological target profiling has increased by approximately 30% in the past year.
Leading R&D organizations, including pharmaceutical, animal health and biotech companies, have increasingly turned to Instem for the production of target safety assessments and demand remains high.
Using the proprietary KnowledgeScan translational informatics platform, Instem quickly and systematically reviews and distills millions of data records from a variety of published sources. These data are then carefully curated, evaluated and interpreted by Instem’s experienced team of life science professionals and presented to clients in a comprehensive, consistent report format.
Dr. Gordon Smith Baxter, Chief Scientific Officer, Instem said “We are delighted to see increasing demand for our KnowledgeScan service and are especially pleased to see so many of our clients returning to us time and again for additional engagements. KnowledgeScan is setting new standards in target safety assessment and is helping clients to make crucial investment decisions based on the most comprehensive intelligence available.”
KnowledgeScan is a unique, technology-enabled service that harnesses cutting-edge augmented intelligence capabilities to deliver comprehensive insight into the potential toxicological risks and challenges associated with modulating drug targets. The service incorporates a unique combination of powerful, computer-aided data acquisition and manipulation, automated workflows and scientific expertise to help clients across the globe make faster, better informed drug development decisions.
For further information download the fact sheet.
Listen to Dr. Baxter’s recent presentation on the latest trends in Target Safety Assessment, presented at the ACT Meeting, Florida, November 7 th – Access the Recording
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005017/en/
CONTACT: Press Contacts:Instem
Tel: +44 (0) 1785 825600Gary Mitchell (US HQ)
KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT HARDWARE OTHER TECHNOLOGY SECURITY HEALTH BIOTECHNOLOGY PHARMACEUTICAL
Copyright Business Wire 2018.
PUB: 12/17/2018 09:30 AM/DISC: 12/17/2018 09:31 AM